Trial Profile
BrUOG 318: FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 May 2023
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 20 Mar 2023 Status changed from active, no longer recruiting to completed.
- 23 Feb 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.
- 12 Aug 2021 Planned End Date changed from 1 Jul 2020 to 1 Dec 2022.